Finally, our hypothesis is complicated by the fact that a plethora of peptides and chemokines are cleaved by DPP4 and CD26 concentrations and DPP4 activity varies between healthy subjects with different medical conditions, making it difficult to predict the effect of DPP4 inhibition on a specific outcome measure such as pneumonia [35]. The gene discussed is DPP4; the disease is pneumonia.